Chemistry and pharma Fault-tolerant quantum computing 'will solve exciting science problems' Quantinuum’s Dr Harry Buhrman and Russell Stutz discuss the technological innovation underpinning the company’s development of fault-tolerant quantum computing systems Latest Content Meta and VSParticle launch catalyst database to accelerate transition to clean energy UK National Quantum lab will open up access to quantum computing in the UK Optibrium demonstrates molecular docking method for small molecules and macrocycles New technologies QC Ware launches Promethium for chemical and materials discovery PhoreMost enhances drug discovery process Optibrium appoints Dr Hamed Tabatabaei Ghomi as Head of Research White papers Leveraging open platforms for scalable quantum computing control systems Quantum computing is complicated, but the infrastructure doesn’t have to be Understanding compound selectivity with data-driven drug design Selectivity is a crucial property in the development of new active pharmaceutical ingredients (APIs). Reducing Risk & Improving Synthesis Outcomes with SYNTHIA Retrosynthesis Software Addressing the many intrinsic and external challenges to chemical synthesis has led to a highly complex system of regulations that invo Webcasts Free Energy Perturbation: How Computational Chemistry Saves Time In Drug Discovery From Data Silos to Data Flow: Unlocking Your Lab with the Right ELN A Cautionary Tale for AI in Small Molecule Drug Discovery More content The latest Chemistry software products for 2023 Pharma 4.0: How connectivity, automation and advanced analytics accelerate innovation QC Ware launches Promethium for chemical and materials discovery PhoreMost enhances drug discovery process Ensuring Analytical Data Accessibility for All Data Consumers Optibrium appoints Dr Hamed Tabatabaei Ghomi as Head of Research How design of experiments lowers costs in R&D Partnership aims to bring pharmaceutical products to market quicker Collaboration aims to advance the discovery of novel cancer drugs Collaboration aims to Integrate AI drug discovery Iktos raises € 15.5m to expand its AI-based drug discovery technology FDA asks for comment on AI manufacturing Pagination Previous page ‹ Previous Page 6 Next page Next ›
